SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Vical Inc., a San Diego-based biopharmaceutical company, announced Thursday that it lost $4.4 million in the third quarter, or 5 cents per share, which is 1 cent below what Wall Street analysts were projecting. The loss is less than half the $9.9 million Vical lost in the same period in 2013.
AMN Healthcare Services Inc., a San Diego-based staffing company, announced quarterly revenue of $265 million for the third quarter of this year.
Zogenix Inc., a San Diego-based pharmaceutical company making products for the treatment of pain-related and central nervous system disorders, announced that it has acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company for $20 million in cash and $15 million in stock, plus potential future milestone and royalty payments.
MEDICINE: Aethlon Device Is Used to Filter Patient’s Blood
A local medical device maker Aethlon Medical Inc. has joined the San Diego effort to develop an Ebola treatment using its experimental blood-filtration system to treat a patient in Germany.
MEDICINE: Specialty Pharma Gets $50M to Support Drug
Cosmederm Bioscience Inc., a La Jolla-based specialty pharmaceutical company, has received a $50 million investment to help expand its TriCalm line — an over-the-counter steroid-free itch reliever that the company hopes will trump well-known competitors like over-the-counter hydrocortisone cream.
HEALTH: The EMR Mandate Opens Door For Industry Innovations
A federal mandate requiring hospitals to install electronic medical record systems has not only streamlined the collection of patient information, it has opened up new markets for innovation in San Diego County and created a new field in health care.
Stepping up California’s preparedness to treat Ebola patients, state public health authorities on Friday officially designated five University of California hospital systems as “priority” hospitals statewide, including UC San Diego Medical Center-Hillcrest.
San Diego-based ResMed Inc., a medical technology company making devices for sleep-related breathing disorders, announced revenue of $380.4 million for the quarter ending Sept. 30, a 6 percent increase compared to the same quarter last year.
Just in time to meet the Ebola outbreak demand for detecting fever, San Diego-based Fraden Corp. announced that it received a second U.S. patent for augmenting any smartphone with an instant non-contact infrared thermometer.
Edico Genome Inc., a San Diego-based company that makes integrated circuits for processing genomic data, announced the broad commercial launch of its flagship Dragen processor.
San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company, announced the appointment of Anthony Yost as chief commercial officer.
San Diego-based Apricus Biosciences Inc. announced that it has acquired $10 million in financing to purchase licensing from Finland-based Forendo Pharma to develop and commercialize an investigational treatment for urological conditions in men.
Epic Sciences Inc. announced the appointment of Michael Giske as chief information officer.
HEALTH: Variety Of Treatments Used to Deal With the Disorder
Military health care organizations in San Diego are investing in research to help staunch undiagnosed post-traumatic stress disorder among soldiers and veterans and to find out which treatments actually work.
BIOTECH: Process To Be More Efficient And More Expansive
The phrase “synthetic biology” might sound like an oxymoron meant for science fiction novels, but it’s not for Synthorx Inc., a small biotechnology company in Torrey Pines. Synthorx is developing a new — and a little bit scary — way to create and protect life.